Dear Editor

When we allowed the Chinese to buy Tyson Meat plants I knew it was just a matter of time and they would try to Hurt us. They are closing Nebraska and calling back meat from Texas, driving beef prices up. Cattle numbers have dropped to a 70 year low. Trump will have to rebuild the ranching industry doing something to increase the size of the herds and the size of the cattle. Then build more processing plants. There is one in Gainesville called Grandma’s meat processing plant. I have talked to them and they sound like they know what they are doing. One of the things some Processing houses don’t take into effect is when the animal is stressed from the trip to the processing plant their adrenaline is peaking they need to calm down before processing. Grass fed beef is bad about that, I talk to a lady that sold Grass fed beef. She had to credit several people because of the stress when they were processed, NOT GOOD! Aging beef can ruin the meat if the fat goes bad way before there beef is effected, so they have to watch that, if they get behind it could ruin the rest of the meat. Continue reading →

(NAPSI)—In local communities across America, the “next big idea” often takes shape in a garage, a small startup office or a community college lab. New American inventors and entrepreneurs are the backbone of our nation. They are responsible for turning bold ideas into products that create jobs and make life easier for all of us. They are often the lifeblood of local economies.

But in recent decades, a particular kind of legal threat has emerged that puts that engine of entrepreneurial innovation at risk. These lawsuits come from shell companies that are commonly known as patent trolls. Patent trolls don’t invent things or make products but exist solely to pursue lawsuits related to patents they buy. Patent troll litigation costs U.S. firms an estimated $29 billion annually in direct legal expenses, and approximately $60 billion when accounting for lost firm value and diverted resources. Patent troll litigation surged 22% from 2023 to 2024 alone, making it a fast-growing issue for American business.

Patent trolls have been at work for decades. But now, in a new twist, patent trolls are being hired to file lawsuits against others in the industry. The aim isn’t to defend a real invention, but to make it harder for rivals by driving up legal costs, scaring off customers, delaying product launches, or pushing for monetary settlements. This puts more pressure on the price of everyday technology products. Continue reading →

(NewsUSA)  – Artificial intelligence is poised to be a game-changer in managing the increasingly congested and poten-tially contested domain of space, from Earth’s orbit to the Moon and beyond, according to a new podcast from the Spe-cial Competitive Studies Project (SCSP), a nonprofit and nonpartisan initiative with a goal of making recommendations to strengthen America’s long-term competitiveness in AI.

At the recent AI + Space Summit hosted by SCSP, General Jay Raymond (U.S. Space Force, Ret.) joined SCSP’s NatSecTech podcast host Jeanne Meserve to discuss the future of space as a warfighting domain. They explore how AI can improve space traffic management, surveillance, acquisition, and data fusion; the growing role of commercial part-nerships; and the need for stronger norms, faster capabilities, and a technically skilled workforce.

Many Eyes in the Sky Continue reading →

(NAPSI)—Good news: According to a recent report from the American Association for Cancer Research (AACR), discoveries across basic, translational, and clinical research as well as population sciences are driving advances in cancer medicine and early detection, leading to a steady decline in the overall U.S. cancer death rate, and allowing more people to live longer and fuller lives after a cancer diagnosis.

From the AACR Cancer Progress Report 2025, here’s a look at some recent breakthroughs.

Between July 1, 2024 and June 30, 2025, the U.S. Food and Drug Administration (FDA) approved 20 new anticancer therapeutics, including:

• the first T-cell receptor (TCR) T-cell therapy, approved for patients with soft tissue sarcoma;
• a new therapeutic antibody targeting a novel protein on stomach cancer cells, which helps those with gastric or gastroesophageal cancer;
• the first IDH-targeted therapy for treating brain tumors, which is bringing new hope to young adult patients who have a mutation in this gene; and
• two new antibody-drug conjugates, both of which were approved to treat lung cancer and one that was also approved to treat breast cancer.

At the same time, FDA also approved:

• new uses for eight previously approved anticancer therapeutics;
• a wearable device that uses low-intensity electrical fields to slow the growth of lung cancer cells;
• two new minimally invasive early detection screening tests, including the first liquid biopsy test and a next-generation multitarget stool DNA test for colorectal cancer screening;
• a device for at-home sample collection for cervical cancer screening; and
• several AI-powered devices and software tools for aiding in cancer risk prediction, diagnosis, and early detection.

Continue reading →

(NAPSI)­—In most of the United States, respiratory illnesses like flu, COVID-19, RSV, and pneumococcal disease consistently show increased activity between October and March. That’s in part because during the fall and winter, people spend more time indoors and close to one another, making it easier for respiratory illnesses to spread.

These infectious diseases can cause more than just a few days of sickness or missed work. In some cases, they can disrupt your life, cause a financial burden, or even lead to complications such as long-term health issues or hospitalization—and infants, older adults and individuals with chronic health conditions are at higher risk for severe illness.

That’s why vaccination is an important step to help stay protected this fall. Getting vaccinated can mean the difference between a mild infection and a severe illness.

Respiratory Vaccines Help Protect You and Those You Love

Vaccination is the best protection—helping to reduce the spread of respiratory illnesses in your community, especially to those most vulnerable.  Continue reading →

(NAPSI)—When it comes to federal spending, the majority of Americans want Congress to make increasing medical research funding a high priority.

A recent national poll conducted by the American Association for Cancer Research (AACR) found very high levels of support for federal funding for medical and cancer research across the electorate.

Highlights of the survey include:

• 89% of voters favor the federal government using taxpayer dollars to fund medical research to fight diseases and improve public health.
• 71% of voters think increasing federal funding for medical research should be a top congressional priority.
• 72% of voters who believe reducing the national debt and federal spending should be a top congressional priority also think increasing medical research funding should be a “high” or “highest” priority issue for Congress.
• 83% of voters, including 75% each of independents, Republicans, and MAGA supporters and 93% of Democrats, favor increasing federal funding for cancer research.
• Voters have high levels of confidence in cancer researchers and the National Cancer Institute (NCI) to act in the best interests of the public. 71% of survey respondents express a “great deal” or “quite a bit” of confidence in cancer researchers, while 65% express a “great deal” or “quite a bit” of confidence in NCI.
• 77% of voters say they would feel more favorable toward their congressional representative if he or she voted to increase federal funding for cancer research over the next decade.

Continue reading →

(Diane Mulligan)  – Small cell lung cancer (SCLC) is among the most aggressive, deadliest forms of lung cancer, yet it’s still too often overlooked. For decades, treatment options were limited, offering little hope to those diagnosed with SCLC, until now.

In 2013, Congress passed legislation that mandated the National Cancer Institute create a scientific plan for treating patients with less than a 50% chance of surviving 5 years. This included SCLC. With this focus on research, SCLC, once considered a hopeless diagnosis because of its swift spread and resistance to standard treatment, is now seeing real momentum. Breakthrough research has increased the number of treatment options by 67% giving doctors new tools and patients new reasons to hope.

Because of research, treatments like the recently FDA-approved Tarlatamab belong to a class of drugs called bispecific T-cell engagers (BiTEs), which harness the immune system to combat cancer. Another treatment, Lurbinectedin, slows or stops the growth of cancer cells in your body.  There are also next-generation approaches, such as CAR T-cell therapy and antibody-drug conjugates, and many others, now in clinical trials. Clinical trials, once a last resort, are rapidly becoming a front door to tomorrow’s breakthroughs.

Early detection is critical. Screening is the best way to find SCLC early. Continue reading →

(NAPSI)—Once the grass gets its final cut and the leaves are handled, it’s time to swap out the mower, blower, and trimmer for the snow thrower, generator, and chainsaw. The Outdoor Power Equipment Institute (OPEI) says a little prep now can mean less stress—and fewer repair bills—later.

“Your end-of-season routine sets the stage for when the weather turns colder,” says Kris Kiser, President and CEO of OPEI, an international trade association representing manufacturers and suppliers of outdoor power equipment, small engines, battery power systems, portable generators, utility and personal transport vehicles, and golf cars. Continue reading →

Happy smart kids with school bags rush to the lessons to school running up the stairs. Back to school. An African-American schoolgirl and her classmate walk down the street after school.

(NAPSI)—Whether your child just started grade school or is considering graduate schools, it’s essential to ensure any online learning needs are seamless and affordable. That starts with making sure they have access to the right broadband Internet speed and bandwidth.

In today’s fast-paced world, slow loading times and interrupted video calls can create frustrating experiences and educational setbacks.

Fortunately, SmartMove has the resources you need to overcome obstacles and turn your home into a high-performance digital hub. At www.smartmove.us/back-to-school-Internet, you’ll find tips like the below: Continue reading →

(NAPSI)—A well-stocked supply of medicine must-haves can sometimes mean the difference between a minor inconvenience and a potential emergency room visit. From summer sunburns to allergy flare-ups, headaches or tummy troubles, keeping stock of appropriate over-the-counter products—and knowing how and when to use them—can help to support health at home.

To help, CVS pharmacists across the country shared their top recommendations for what every household should consider having on hand, including some surprising items consumers might not think of. Whether you’re restocking your first-aid kit, preparing for seasonal allergies or updating your emergency supplies, CVS Pharmacy can make it easy to build a collection of essentials that support everyday and unexpected health needs. Continue reading →